Armata Pharmaceuticals, Inc. Common Stock (ARMP)
R&D Expense Growth
-31.11%
Fiscal year · Period ending:
ARMP R&D Expense Growth
Latest reported-31.11%period ending
Latest reported-31.11%period ending
ARMP FY R&D Growth (YoY) (0.00% → -31.11%)
Latest values, visible window
High-resolution chart · PNG
ARMP r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -31.1073% | |
| 1.9426% | |
| -3.5611% | |
| 74.9538% | |
| 38.5696% | |
| 47.0277% | |
| 100.8177% | |
| 69.8022% | |
| -49.2603% | |
| 42.2345% | |
| -31.2317% | |
| -10.7198% | |
| 339.3243% | |
| 0% | |
| -100% | |
| -14.2639% | |
| 22.2828% | |
| -20.4242% | |
| 5.2696% | |
| 0.5292% | |
| -41.4849% | |
| -6.8376% | |
| 63.3492% | |
| 35.049% | |
| 7.5188% | |
| 2.3077% | |
| 13.0435% | |
| 40.2439% | |
| 20.5882% | |
| 0% | |
| 0% |